A randomized, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women.

MLA

Juhl, Christian R., et al. “A Randomized, Double‐blind, Crossover Study of the Effect of the Fluoroquinolone Moxifloxacin on Glucose Levels and Insulin Sensitivity in Young Men and Women.” Diabetes, Obesity & Metabolism, vol. 25, no. 1, Jan. 2023, pp. 98–109. EBSCOhost, https://doi.org/10.1111/dom.14851.

APA

Juhl, C. R., Burgdorf, J., Knudsen, C., Lubberding, A. F., Veedfald, S., Isaksen, J. L., Hartmann, B., Frikke, S. R., Mandrup, P. T., Holst, J. J., Kanters, J. K., & Torekov, S. S. (2023). A randomized, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women. Diabetes, Obesity & Metabolism, 25(1), 98–109. https://doi.org/10.1111/dom.14851

Chicago

Juhl, Christian R., Josephine Burgdorf, Cecilie Knudsen, Anniek F. Lubberding, Simon Veedfald, Jonas L. Isaksen, Bolette Hartmann, et al. 2023. “A Randomized, Double‐blind, Crossover Study of the Effect of the Fluoroquinolone Moxifloxacin on Glucose Levels and Insulin Sensitivity in Young Men and Women.” Diabetes, Obesity & Metabolism 25 (1): 98–109. doi:10.1111/dom.14851.